Literature DB >> 18958496

Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.

Fu-Sung Lo1, Ju-Li Lin, Min-Tzu Kuo, Pao-Chin Chiu, San-Ging Shu, Mei-Chyn Chao, Yann-Jinn Lee, Shuan-Pei Lin.   

Abstract

Noonan syndrome is a highly variable disorder that has significant phenotypic overlap with Costello syndrome and cardio-facio-cutaneous syndrome. KRAS mutation was the second reported gene for Noonan syndrome. This study screened for mutation of the KRAS gene in 57 unrelated ethnic Chinese children suffering from Noonan syndrome without PTPN11 gene mutation in Taiwan. This work only identified two patients with different missense mutations (c.40G>A, p.Val14Ile; c.108A>G, p.Ile36Met) in the exon 1 of KRAS gene. This study also analyzed the characteristics of 34 reported cases involving KRAS mutations in the literature. All these patients presented with variable phenotypes, including Noonan syndrome (n = 19), cardio-facio-cutaneous syndrome (n = 7), Costello syndrome (n = 6), and Noonan/cardio-facio-cutaneous syndrome (n = 1). The phenotype of KRAS mutations was generally severe, including short stature, mental retardation, heart defects, etc. In conclusion, this investigation demonstrates that KRAS mutations are the cause in a minority of cases of Chinese patients with Noonan syndrome in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958496     DOI: 10.1007/s00431-008-0858-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  Genotype-phenotype correlations in Noonan syndrome.

Authors:  Martin Zenker; Gernot Buheitel; Ralf Rauch; Rainer Koenig; Kirstin Bosse; Wolfram Kress; Hans-Ulrich Tietze; Helmuth-Guenther Doerr; Michael Hofbeck; Helmut Singer; André Reis; Anita Rauch
Journal:  J Pediatr       Date:  2004-03       Impact factor: 4.406

2.  Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.

Authors:  Martin Zenker; Katarina Lehmann; Anna Leana Schulz; Helmut Barth; Dagmar Hansmann; Rainer Koenig; Rudolf Korinthenberg; Martina Kreiss-Nachtsheim; Peter Meinecke; Susanne Morlot; Stefan Mundlos; Anne S Quante; Salmo Raskin; Dirk Schnabel; Lars-Erik Wehner; Christian P Kratz; Denise Horn; Kerstin Kutsche
Journal:  J Med Genet       Date:  2006-10-20       Impact factor: 6.318

3.  Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome.

Authors:  Chia-Sui Hung; Ju-Li Lin; Yann-Jinn Lee; Shuan-Pei Lin; Mei-Chyn Chao; Fu-Sung Lo
Journal:  J Formos Med Assoc       Date:  2007-02       Impact factor: 3.282

4.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

5.  Further evidence of genetic heterogeneity in Costello syndrome: involvement of the KRAS gene.

Authors:  Débora Romeo Bertola; Alexandre Costa Pereira; Amanda Salem Brasil; Lilian Maria José Albano; Chong Ae Kim; José Eduardo Krieger
Journal:  J Hum Genet       Date:  2007-04-28       Impact factor: 3.172

6.  Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.

Authors:  Caroline Nava; Nadine Hanna; Caroline Michot; Sabrina Pereira; Nathalie Pouvreau; Tetsuya Niihori; Yoko Aoki; Yoichi Matsubara; Benoit Arveiler; Didier Lacombe; Eric Pasmant; Béatrice Parfait; Clarisse Baumann; Delphine Héron; Sabine Sigaudy; Annick Toutain; Marlène Rio; Alice Goldenberg; Bruno Leheup; Alain Verloes; Hélène Cavé
Journal:  J Med Genet       Date:  2007-08-17       Impact factor: 6.318

Review 7.  What's new in the neuro-cardio-facial-cutaneous syndromes?

Authors:  Ellen Denayer; Eric Legius
Journal:  Eur J Pediatr       Date:  2007-07-05       Impact factor: 3.183

8.  Germline KRAS mutations cause Noonan syndrome.

Authors:  Suzanne Schubbert; Martin Zenker; Sara L Rowe; Silke Böll; Cornelia Klein; Gideon Bollag; Ineke van der Burgt; Luciana Musante; Vera Kalscheuer; Lars-Erik Wehner; Hoa Nguyen; Brian West; Kam Y J Zhang; Erik Sistermans; Anita Rauch; Charlotte M Niemeyer; Kevin Shannon; Christian P Kratz
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

9.  Tumor development in three patients with Noonan syndrome.

Authors:  Helen Fryssira; George Leventopoulos; Stavroula Psoni; Sophia Kitsiou-Tzeli; Nikolaos Stavrianeas; Emmanuel Kanavakis
Journal:  Eur J Pediatr       Date:  2007-12-05       Impact factor: 3.183

10.  Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.

Authors:  Claudio Carta; Francesca Pantaleoni; Gianfranco Bocchinfuso; Lorenzo Stella; Isabella Vasta; Anna Sarkozy; Cristina Digilio; Antonio Palleschi; Antonio Pizzuti; Paola Grammatico; Giuseppe Zampino; Bruno Dallapiccola; Bruce D Gelb; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2006-05-01       Impact factor: 11.025

View more
  10 in total

1.  Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.

Authors:  Masako Yaoita; Tetsuya Niihori; Seiji Mizuno; Nobuhiko Okamoto; Shion Hayashi; Atsushi Watanabe; Masato Yokozawa; Hiroshi Suzumura; Akihiko Nakahara; Yusuke Nakano; Tatsunori Hokosaki; Ayumi Ohmori; Hirofumi Sawada; Ohsuke Migita; Aya Mima; Pablo Lapunzina; Fernando Santos-Simarro; Sixto García-Miñaúr; Tsutomu Ogata; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Shin-Ichi Inoue; Yoichi Matsubara; Shigeo Kure; Yoko Aoki
Journal:  Hum Genet       Date:  2015-12-29       Impact factor: 4.132

Review 2.  Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations.

Authors:  Nao Yoshida; Sayoko Doisaki; Seiji Kojima
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

3.  Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.

Authors:  Lothar Gremer; Torsten Merbitz-Zahradnik; Radovan Dvorsky; Ion C Cirstea; Christian Peter Kratz; Martin Zenker; Alfred Wittinghofer; Mohammad Reza Ahmadian
Journal:  Hum Mutat       Date:  2010-12-09       Impact factor: 4.878

Review 4.  Post-translational modification of RAS proteins.

Authors:  Sharon L Campbell; Mark R Philips
Journal:  Curr Opin Struct Biol       Date:  2021-08-06       Impact factor: 6.809

5.  K-RasV14I recapitulates Noonan syndrome in mice.

Authors:  Isabel Hernández-Porras; Salvatore Fabbiano; Alberto J Schuhmacher; Alexandra Aicher; Marta Cañamero; Juan Antonio Cámara; Lorena Cussó; Manuel Desco; Christopher Heeschen; Francisca Mulero; Xosé R Bustelo; Carmen Guerra; Mariano Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-30       Impact factor: 11.205

6.  RASopathy in Patients With Isolated Sagittal Synostosis.

Authors:  Amani Ali Davis; Giulio Zuccoli; Mostafa M Haredy; Joseph Losee; Ian F Pollack; Suneeta Madan-Khetarpal; Jesse A Goldstein; Ken K Nischal
Journal:  Glob Pediatr Health       Date:  2019-05-12

7.  Identification of lysine methylation in the core GTPase domain by GoMADScan.

Authors:  Hirofumi Yoshino; Guowei Yin; Risa Kawaguchi; Konstantin I Popov; Brenda Temple; Mika Sasaki; Satoshi Kofuji; Kara Wolfe; Kaori Kofuji; Koichi Okumura; Jaskirat Randhawa; Akshiv Malhotra; Nazanin Majd; Yoshiki Ikeda; Hiroko Shimada; Emily Rose Kahoud; Sasson Haviv; Shigeki Iwase; John M Asara; Sharon L Campbell; Atsuo T Sasaki
Journal:  PLoS One       Date:  2019-08-07       Impact factor: 3.240

Review 8.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

9.  An Association of PTPN11 and SHOX Mutations in a Male Presenting With Syndromic Growth Failure.

Authors:  Emanuela Savarese; Benedetta Di Felice; Francesco Miconi; Gabriele Cabiati; Federica Celi; Francesco Crescenzi; Nicola Principi; Susanna Esposito
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-20       Impact factor: 5.555

10.  Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.

Authors:  Yah-Huei Wu-Chou; Tzu-Chao Hung; Yin-Ting Lin; Hsing-Wen Cheng; Ju-Li Lin; Chih-Hung Lin; Chung-Chih Yu; Kuo-Ting Chen; Tu-Hsueh Yeh; Yu-Ray Chen
Journal:  J Biomed Sci       Date:  2018-10-05       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.